BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 08, 2011
 |  BioCentury  |  Product Development

HIV Trojan horse

Virxsys turns HIV's ability to infect cells against the virus in T cell vaccine

HIV's ability to hide out in the body in places that drugs can't reach has helped the virus remain resistant to eradication. But Virxsys Corp. thinks its VRX1273 may be able to provide a functional cure for some patients by reaching all the walls into these disease reservoirs.

The therapeutic T cell vaccine hijacks HIV's ability to infect cells by gutting the virus and using it as the vector. The compound produced functional cures in 40% of monkeys 18 months after a viral challenge, according to data presented last month.

"For the last several years the idea of a functional cure...

Read the full 493 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >